Capital Insight Partners’s Chemed CHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-848
| Closed | -$363K | – | 21 |
|
|
2025
Q4 | $363K | Sell |
848
-6,372
| -88% | -$2.77M | 0.08% | 112 |
|
|
2025
Q3 | $3.23M | Sell |
7,220
-2,027
| -22% | -$918K | 0.54% | 56 |
|
|
2025
Q2 | $4.5M | Sell |
9,247
-1,307
| -12% | -$745K | 0.78% | 39 |
|
|
2025
Q1 | $6.49M | Sell |
10,554
-79
| -0.7% | -$44.9K | 1.13% | 28 |
|
|
2024
Q4 | $5.63M | Buy |
10,633
+539
| +5% | +$304K | 0.97% | 32 |
|
|
2024
Q3 | $6.07M | Buy |
10,094
+314
| +3% | +$178K | 1.06% | 29 |
|
|
2024
Q2 | $5.31M | Sell |
9,780
-192
| -2% | -$110K | 1% | 33 |
|
|
2024
Q1 | $6.4M | Buy |
9,972
+700
| +8% | +$425K | 1.2% | 20 |
|
|
2023
Q4 | $5.42M | Buy |
9,272
+48
| +0.5% | +$26.9K | 1.11% | 19 |
|
|
2023
Q3 | $4.79M | Buy |
9,224
+328
| +4% | +$171K | 1.09% | 20 |
|
|
2023
Q2 | $4.82M | Sell |
8,896
-154
| -2% | -$84.2K | 1.08% | 19 |
|
|
2023
Q1 | $4.87M | Buy |
+9,050
| New | +$4.61M | 1.14% | 19 |
|
|
2022
Q4 | – | Sell |
-9,108
| Closed | -$3.98M | – | 159 |
|
|
2022
Q3 | $3.98M | Sell |
9,108
-106
| -1% | -$51K | 1.07% | 23 |
|
|
2022
Q2 | $4.33M | Buy |
9,214
+173
| +2% | +$84.4K | 1.01% | 24 |
|
|
2022
Q1 | $4.58M | Buy |
9,041
+642
| +8% | +$308K | 0.93% | 29 |
|
|
2021
Q4 | $4.44M | Buy |
8,399
+426
| +5% | +$205K | 0.9% | 34 |
|
|
2021
Q3 | $3.71M | Buy |
7,973
+484
| +6% | +$228K | 0.81% | 35 |
|
|
2021
Q2 | $3.55M | Buy |
7,489
+766
| +11% | +$368K | 0.8% | 40 |
|
|
2021
Q1 | $3.09M | Buy |
6,723
+494
| +8% | +$242K | 0.75% | 42 |
|
|
2020
Q4 | $3.32M | Buy |
6,229
+105
| +2% | +$51.6K | 0.84% | 38 |
|
|
2020
Q3 | $2.94M | Buy |
6,124
+108
| +2% | +$53K | 0.83% | 35 |
|
|
2020
Q2 | $2.71M | Buy |
6,016
+20
| +0.3% | +$8.93K | 0.86% | 34 |
|
|
2020
Q1 | $2.6M | Buy |
5,996
+373
| +7% | +$167K | 1.37% | 16 |
|
|
2019
Q4 | $2.47M | Buy |
5,623
+70
| +1% | +$29.4K | 1.13% | 25 |
|
|
2019
Q3 | $2.32M | Sell |
5,553
-221
| -4% | -$90.2K | 2.03% | 14 |
|
|
2019
Q2 | $2.08M | Sell |
5,774
-113
| -2% | -$37.8K | 1.81% | 18 |
|
|
2019
Q1 | $1.88M | Sell |
5,887
-68
| -1% | -$20.9K | 1.7% | 22 |
|
|
2018
Q4 | $1.69M | Sell |
5,955
-9
| -0.2% | -$2.72K | 1.74% | 22 |
|
|
2018
Q3 | $1.91M | Sell |
5,964
-783
| -12% | -$250K | 1.68% | 25 |
|
|
2018
Q2 | $2.17M | Sell |
6,747
-102
| -1% | -$31.9K | 1.79% | 22 |
|
|
2018
Q1 | $1.87M | Sell |
6,849
-19
| -0.3% | -$5.03K | 1.52% | 28 |
|
|
2017
Q4 | $1.67M | Sell |
6,868
-50
| -0.7% | -$11.4K | 1.31% | 37 |
|
|
2017
Q3 | $1.4M | Buy |
6,918
+279
| +4% | +$54.8K | 1.18% | 44 |
|
|
2017
Q2 | $1.36M | Sell |
6,639
-435
| -6% | -$86.6K | 1.2% | 41 |
|
|
2017
Q1 | $1.29M | Buy |
7,074
+30
| +0.4% | +$5.23K | 1.17% | 41 |
|
|
2016
Q4 | $1.13M | Buy |
7,044
+148
| +2% | +$21.7K | 1.12% | 39 |
|
|
2016
Q3 | $973K | Buy |
+6,896
| New | +$960K | 0.94% | 44 |
|
Other funds holding CHE
VPM
VCM
Capital Insight Partners's CHE Position: Q1 2026 in Review
Capital Insight Partners sold out of Chemed (CHE) in Q1 2026, closing a stake of 848 shares — an estimated $363K sold.
Capital Insight Partners first reported a position in CHE in Q3 2016 and held it in 37 quarters. The position peaked at $6.49M in Q1 2025. 488 funds tracked by Wall St. Rank hold CHE as of Q1 2026.
- Capital Insight Partners reported no remaining Chemed position as of Q1 2026 after selling out during the quarter.
- Capital Insight Partners sold 848 Chemed shares in Q1 2026, an estimated $363K.
- Capital Insight Partners first reported a position in Chemed in Q3 2016 and held it in 37 quarters.
- Capital Insight Partners's Chemed position peaked at $6.49M in Q1 2025.
- 488 funds tracked by Wall St. Rank held Chemed as of Q1 2026.
Based on Capital Insight Partners's 13F filing for Q1 2026.